what are the side effects of glp-1 injections Your guide to From nausea and exhaustion to

What the evidence actually says in 2026: Suicide risk: FDA reviewed the data and on Jan 13, 2026 requested removal of the suicidal ideation warning from GLP-1 labels no increased risk found

The results highlight a potentially differentiated profile combining substantial weight loss, favorable tolerability, and a dual formulation strategy

Dakin et al

And rather than pushing the body harder, NAD will help it better cope with the changes already underway

The key practical difference: tirzepatide (sold as Zepbound and Mounjaro) is approved and available now

Generic forms of semaglutide may be available at a lower cost than brand-name Ozempic